Premium
Incidental Carcinoma of the Prostate: Selection for Deferred Treatment
Author(s) -
BEY L. L.,
BUSUTTIL A.,
NEWSAM J. E.,
CHISHOLM G. D.
Publication year - 1983
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1983.tb03415.x
Subject(s) - medicine , grading (engineering) , prostate , prostate cancer , stage (stratigraphy) , carcinoma , presentation (obstetrics) , disease , cancer , oncology , radiology , paleontology , civil engineering , engineering , biology
Summary— Fifty‐one of 212 consecutive patients with prostatic cancer presented with incidentally diagnosed (TO) cancer. The average age at presentation was 73 years and follow‐up ranged from 1 to 62 months. Deferred treatment was selected in 39 cases, 10 of which progressed. Of 15 deaths only 3 were related to prostate cancer and these were patients who had presented with metastases. Histological grading by the Gleason system demonstrated a significant correlation with metastatic stage at presentation and tumour bulk, but not with age or progression in deferred treatment cases. It is concluded that there is a need to subdivide patients presenting with incidental carcinoma, that tumour bulk correlates with histological grade and that future treatment protocols for TO disease should stratify for histological grade.